Biosimilars Value Strategy Director

Role Summary

The Director, Biosimilars Value Strategy will lead the development, championing, and execution of the value marketing strategy for Pfizer US Biosimilars across managed markets, hospital systems, and GPO segments. The role is a key member of the US Commercial Biosimilars Team, collaborating with cross-functional partners to identify and capitalize on opportunities for the US biosimilar portfolio. The Director reports to the US Commercial Biosimilars Portfolio Lead. Location: Hybrid.

Responsibilities

• Partner to develop and execute the GH&B US biosimilars brand strategy and portfolio opportunities within the hospital and clinic channels with PAN portfolio responsibility
• Synthesize multiple secondary data sources to identify potential threats and opportunities to brand coverage and performance in key large national payer and provider health systems
• Provide key input to guide the implementation of strategic and operating plans and latest estimate forecasts
• Make recommendations on pricing, contracting offers across provider, payer, GPO that will impact long-range forecast development
• Support US Commercial Biosimilar team to ensure robust financial forecasting of the business reflecting prevailing market dynamics and portfolio characteristics (payer and provider contracting, ASP dynamics, projected supply availability, margins, etc)
• Partner with US Commercial teams (Hospital Portfolio, Pricing & Commercial Operations, Sales & Customer Facing Business, Marcom, Customer Enablement and Service, Contracting and Rebate Operations), Global Hospital & Biosimilar team (Finance, Manufacturing, Portfolio & Lifecycle Management, Commercial Excellence and Innovation), and other key functions (USMA, Policy and Government Relations, Medical, etc) to deliver and execute strategies and tactics that advance business goals of implementing and achieving the strategic and operating plans, while ensuring high customer satisfaction
• Develop unique value based contractual offerings to key large payers and IDN systems
• Model financial scenarios that inform value offering long-term business impact
• Strategically balance trade-offs across provider, payer, and GPO offers

Qualifications

• Bachelor’s degree with at least 8 years of experience OR Master’s degree with more than 7 years of experience OR a PhD with 5 years of experience OR MD/VDM with 4 years of experience
• Relevant commercial experience in the pharmaceutical industry (i.e., strategic planning, pricing, value marketing)
• Experience with US buy-and-bill biologics marketplace, ASP-based reimbursement, and key value chain players
• Proven ability to analyze complex data, model financial impact, and develop and implement related strategic recommendations
• Ability to lead initiatives in a highly matrixed environment and gain buy in across multiple groups across Pfizer
• Ability to take accountability for business challenges and tackle complex problems
• Strong customer-orientation; an ability to see issues from the point of view of others; an "execution mindset" focused on getting things done quickly
• Outstanding writing, oral and presentation skills; ability to convey and effectively communicate market analytics, project proposals and strategies, and the results of complex data analyses to diverse audiences
• High level of integrity, transparency of conduct

Skills

• Strong written and oral communication; ability to convey market analytics and strategic proposals to diverse audiences
• Advanced analytical and financial modeling capabilities
• Strategic thinking with ability to drive execution in a matrixed organization
• Customer orientation with empathy and perspective-taking
• Execution mindset with a focus on delivering results
• High integrity and transparent conduct